Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GSK172981 is a non-peptide tachykinin NK3 receptor antagonist with a high affinity for the recombinant human (PK (I) value 7.7) and native guinea pig (PK (I) value 7.8) tachykinin NK3 receptor. In vitro, the functional evaluation showed that GSK172981 was a competitive antagonist for the cloned human tachykinin NK(3) receptor (PA (2)=7.2). GSK172981 may be used to treat schizophrenia.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | Inquiry | Inquiry | |
500 mg | Inquiry | Inquiry |
Description | GSK172981 is a non-peptide tachykinin NK3 receptor antagonist with a high affinity for the recombinant human (PK (I) value 7.7) and native guinea pig (PK (I) value 7.8) tachykinin NK3 receptor. In vitro, the functional evaluation showed that GSK172981 was a competitive antagonist for the cloned human tachykinin NK(3) receptor (PA (2)=7.2). GSK172981 may be used to treat schizophrenia. |
Synonyms | GSK 172981, GSK-172981 |
Molecular Weight | 411.47 |
Formula | C26H22FN3O |
CAS No. | 1133705-99-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GSK172981 1133705-99-3 GSK 172981 GSK-172981 inhibitor inhibit